RedHill Biopharma (RDHL) Earnings
|
Expand Research on RDHL
| Next EPS Date | 5/27/22 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +77.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +28.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/17/22 |  |
Q421 | $0.00 | -$0.33 | +$0.33 | $22.1M | $24.08M | N/A |  | | Details |
| 11/30/21 | |
Q321 | -$0.05 | -$0.21 | +$0.16 | $21.6M | $24.52M | N/A | | | Details |
| 8/26/21 | |
Q221 | -$0.06 | -$0.12 | +$0.06 | $21.5M | $25.02M | N/A | | | Details |
| 5/27/21 | |
Q121 | -$0.05 | -$0.34 | +$0.29 | $20.6M | $22.7M | N/A | | | Details |
3/18/21  |
|
Q420 | $0.00 | -$0.24 | +$0.24 | N/A | $26.03M | N/A | | | Details |
| 11/12/20 | |
Q320 | $0.05 | -$0.16 | +$0.21 | $20.9M | $25.37M | N/A | | | Details |
| 8/13/20 | |
Q220 | -$0.04 | -$0.07 | +$0.03 | $20.9M | $22.99M | N/A | | | Details |
| 11/19/19 | |
Q319 | $0.03 | -$0.38 | +$0.41 | $1.4M | $1.77M | N/A | | | Details |
